San Francisco–based Decagon, which develops conversational AI agents, has raised $250 million in a Series D round led by Coatue and Index Ventures. The deal underscores the continued flow of large-scale capital into artificial intelligence as investors double down on the sector’s growth potential.
Biotech also drew strong interest. Tenpoint Therapeutics, focused on treatments for degenerative eye diseases, secured $85 million in Series B funding led by Janus Henderson, EQT Nexus, Hillhouse and the British Business Bank, alongside a $150 million debt facility from Hercules Capital. Elsewhere, Belgian biotech Agomab Therapeutics is preparing to go public, targeting a valuation of about $780 million at the midpoint of its proposed price range.lion from investors including AMD, Meta and Intel Capital.
Several other startups announced sizable raises across technology and industrials. PaleBlueDot AI closed a $150 million Series B led by B Capital, RobCo raised $100 million in a Series C led by Lightspeed and Lingotto Innovation, and Eliyan secured $50 million from backers including AMD, Meta and Intel Capital.
Private equity activity was equally robust. KKR is in talks to acquire a €2.75 billion stake in CVC Capital Partners’ Global Sport Group, while Bain Capital and Blackstone are bidding for British vitamins maker Vitabiotics. The Carlyle Group agreed to acquire most of Lukoil’s international assets, and Nordic Capital bought a majority stake in Swiss fund manager services provider 1741 Group.
Public market plans are also gaining momentum. Blackstone-backed Liftoff Mobile is seeking to raise up to $762 million in an IPO at a target valuation of $5.2 billion. Sandwich chain Jersey Mike’s has appointed Morgan Stanley and JPMorgan to lead its IPO, which is expected to raise more than $1 billion.
On the venture capital front, Reed Jobs is raising $350 million for the second flagship fund of Yosemite, his investment firm. Paris-based Daphni reached a €260 million final close for its science-focused Blue Fund, while German media group Bertelsmann announced plans to launch a $200 million venture fund dedicated to healthtech investments.
